-
1 Comment
Apeloa Pharmaceutical Co.,Ltd is currently in a long term uptrend where the price is trading 10.2% above its 200 day moving average.
From a valuation standpoint, the stock is 54.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.4.
Apeloa Pharmaceutical Co.,Ltd's total revenue rose by 15.2% to $2B since the same quarter in the previous year.
Its net income has increased by 53.2% to $187M since the same quarter in the previous year.
Finally, its free cash flow fell by 130.0% to $-83M since the same quarter in the previous year.
Based on the above factors, Apeloa Pharmaceutical Co.,Ltd gets an overall score of 4/5.
| Sector | Healthcare |
|---|---|
| Industry | Drug Manufacturers - Specialty & Generic |
| Exchange | SHE |
| CurrencyCode | CNY |
| ISIN | CNE000000Q45 |
| Market Cap | 16B |
|---|---|
| Dividend Yield | 2.3% |
| Beta | 0.46 |
| Target Price | 19.425 |
| PE Ratio | 15.35 |
Apeloa Pharmaceutical Co.,Ltd provides raw materials and intermediates to various pharmaceutical factories in the People's Republic of China and internationally. The company offers preparation products, including cardio-cerebrovascular, anti-infection, anti-tumor, anti-viral, and special drugs. It offers its products under the Tianliwei, Beshin, Yosemade, Jutai, and other brands. Apeloa Pharmaceutical Co.,Ltd was founded in 1989 and is based in Dongyang, the People's Republic of China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 000739.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
